:::
 

English:

Personal Information:                                                                                                                      
                                                                                                                                      

Name:    
I-Tsu Chyuan (全以祖)

Work address:

Department of Internal Medicine
Cathay General Hospital
No.280, Sec. 4, Ren’ai Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C.)
Tel: (886)-2-27082121 ext. 3210
E-mail: itchyuan@gmail.com

Present position:

Attending Physician, Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan
Adjunct Attending Physician, Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Assistant Professor, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan
 

Education:                                                                                                                    

2014-2018

PhD. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

1998-2005

M.D. School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Professional Experience:

2019-

Assistant Professor, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan

2014-

Attending Physician, Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan

2012-2014

Attending Physician, Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin Chu, Taiwan

2010-2012

Fellowship, Division of Allergy, Division of Immunology and Rheumatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

2007-2010

Residency, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Professional Societies:

Taiwan Rheumatology Association
Chinese Society of Immunology
Taiwan Society of Internal Medicine
Taiwan Society of Ultrasound in Medicine

Special Honors and Awards:

2019
2019

2018

The Shen Shui-De Award in Chinese Immunology Society
Travel Award in 7th Annual Meeting of Asian Organization for Crohn’s and Colitis
The Shen Shui-De Award in Chinese Immunology Society

2018

The Award for Best Oral Presentation in the 33rd Joint Annual Conference of Biomedical Science

2016

The Award for Best Oral Presentation in Chinese Immunology Society

2015

The Shen Shui-De Award in Chinese Immunology Society

Publications:

*Huang SW, *Chyuan IT, Shiue C, Yu MC, Hsu YF, Hsu MJ. Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade. J Cell Mol Med. 2019 (* co-first author) (in press). (SCI)
Tzeng HT, Chyuan IT, Chen WY. Shaping of innate immune response by fatty acid metabolite palmitate. Cells. 2019;8(12). (SCI)
Chyuan IT, Tzeng HT, Chen JY. Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus. Cells. 2019;8(9). (SCI)
Chyuan IT, Tsai HF, Wu CS, Hsu PN. TRAIL suppresses gut inflammation and inhibits colitogenic T cell activation in experimental colitis via an apoptosis-independent pathway. Mucosal Immunol. 2019;12(4):980-989 (SCI)
Liao HJ, Tsai HF, Wu CS, Chyuan IT, Hsu PN. TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment. Cell Death Dis. 2019;10(2):77. (SCI)
Chyuan IT, Chen JY. Role of Interleukin-(IL-)17 in the pathogenesis and targeted therapies in spondyloarthropathies. Mediators Inflamm. 2018;2018:2403935. (SCI)
Chyuan IT, Tsai HF, Wu CS, Sung CC, Hsu PN. TRAIL-mediated suppression of T cell receptor signaling inhibits T cell activation and inflammation in experimental autoimmune encephalomyelitis. Front Immunol. 2018;9:15. (SCI)
Chyuan IT, Hsu PN. Tumor necrosis factor: The key to hepatitis B viral clearance. Cell Mol Immunol. 2018;15(8):731-733. (SCI)
Yang NY, Wang CY, Chyuan IT, Wu KJ, Tu YK, Chang CW, Hsu PN, Kuo MY, Chen YW. Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy. J Formos Med Assoc. 2018;117(11):1003-1010. (SCI)
Chyuan IT, Tsai HF, Liao HJ, Wu CS, Hsu PN. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T cell activation in inflammatory arthritis. Cell Mol Immunol. 2018;15(9):846-857. (SCI)
Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN. Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. J Mol Med (Berl). 2016;94(5):545-56 (SCI)
Wang CY, Chyuan IT, Wang YL, Kuo MY, Chang CW, Wu KJ, Hsu PN, Nagasawa T, Wara-Aswapati N, Chen YW. β2-glycoprotein I-dependent anti-CL antibodies associated with periodonitis in SLE patients. J Periodontol. 2015;86(8):995-1004. (SCI)
Chyuan IT, Tsai HF, Tzeng HT, Sung CC, Wu CS, Chen PJ, Hsu PN. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T cell exhaustion in a mouse model. Cell Mol Immunol. 2015;12(3):317-25. (SCI)
*Liao HJ, *Chyuan IT, Wu CS, Lin SW, Chen KH, Tsai HF, Hsu PN. Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology. 2015;54(7):1317-26 (* co-first author) (SCI)
Chyuan IT, Tsai TH, Chang TH, Wu CS. Ustekinumab treatment in a patient with psoriasis and systemic lupus erythematosus. Lupus. 2015;24(6):650-1. (SCI)
Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, Hsu PN. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One. 2014;9(7):e103008. (SCI)
Wu CS, Hu CY, Tsai HF, Chyuan IT, Chan CJ, Chang SK, Hsu PN. Elevated serum level of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus patients is associated with nephritis and cutaneous vasculitis. Rheumatol Int. 2014;34(5):625-9. (SCI)

更新時間:2020/2/5